Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.710
+0.010 (0.59%)
Aug 13, 2025, 4:00 PM - Market closed
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $9.46 million as of August 13, 2025. Its market cap has decreased by -56.01% in one year.
Market Cap
9.46M
Enterprise Value
-7.13M
1-Year Change
-56.01%
Ranking
Category
Stock Price
$1.71
Market Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $9.46M, a decrease of -50.05%. That is a compound annual growth rate of -19.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 9.40M | -47.41% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |